EUVIMEDEUVIMED entdecken
Crossref

Porphyrin-Engineered 125 I-Nanoseeds as a Prototype for Immunogenic Brachytherapy

Zhiyu Tu, Ziyang Sang, Yang Xu, Weiqiu Liang, Simiao Qiao, Qi Sun, Kongchang Feng, Ziren Kong, Hao Wang, Zhibo Liu iD

Journal of the American Chemical Society · 2025

DOI: 10.1021/jacs.4c17573 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Chemical Society, 2025. Verfasst von Zhiyu Tu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Beijing National Laboratory for Molecular Sciences, Radiochemistry and Radiation Chemistry, Key Laboratory of Fundamental Science, Key Laboratory of …. Hauptthemen laut MEDLINE: Brachytherapy, Iodine Radioisotopes, Porphyrins. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Ministry of Science and Technology of the People's Republic of China, Natural Science Foundation of Beijing Municipality, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BrachytherapyIodine RadioisotopesPorphyrinsAnimalsMiceHumansCell Line, TumorFemaleNeoplasms

Substanzen

Iodine RadioisotopesIodine-125Porphyrins

Autor:innen und Institutionen

  • Beijing National Laboratory for Molecular Sciences, Radiochemistry and Radiation Chemistry, Key Laboratory of Fundamental Science, Key Laboratory of Bioorganic Chemistry and Molecular Engineering of Ministry of Educatio…
  • Changping Laboratory, Beijing 102206, China.
  • Peking University-Tsinghua University Center for Life Sciences, Peking University, Beijing 100871, China.
  • Department of Head and Neck Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
  • Cancer Center, Peking University Third Hospital, Beijing 100191, China.
  • Department of Radiation Oncology, Peking University Third Hospital, Beijing 100191, China.

ORCID-Profile: Zhibo Liu

Förderung

  • Ministry of Science and Technology of the People's Republic of China
  • Natural Science Foundation of Beijing Municipality
  • National Natural Science Foundation of China
  • Changping Laboratory

Zitieren

APA

Tu, Z., Sang, Z., Xu, Y., Liang, W., Qiao, S., Sun, Q., Feng, K., Kong, Z., Wang, H., & Liu, Z. (2025). Porphyrin-Engineered 125 I-Nanoseeds as a Prototype for Immunogenic Brachytherapy. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.4c17573

Vancouver

Tu Z, Sang Z, Xu Y, Liang W, Qiao S, Sun Q, et al. Porphyrin-Engineered 125 I-Nanoseeds as a Prototype for Immunogenic Brachytherapy. Journal of the American Chemical Society. 2025. doi:10.1021/jacs.4c17573

BibTeX
@article{Tu2025,
  author = {Tu, Zhiyu and Sang, Ziyang and Xu, Yang and Liang, Weiqiu and Qiao, Simiao and Sun, Qi and Feng, Kongchang and Kong, Ziren and Wang, Hao and Liu, Zhibo},
  title = {Porphyrin-Engineered 125 I-Nanoseeds as a Prototype for Immunogenic Brachytherapy},
  journal = {Journal of the American Chemical Society},
  year = {2025},
  doi = {10.1021/jacs.4c17573}
}
Kostenlos starten →